vs

Side-by-side financial comparison of DigitalBridge Group, Inc. (DBRG) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $105.7M, roughly 2.0× DigitalBridge Group, Inc.). On growth, DigitalBridge Group, Inc. posted the faster year-over-year revenue change (4.1% vs -0.4%). Over the past eight quarters, DigitalBridge Group, Inc.'s revenue compounded faster (19.2% CAGR vs 1.9%).

DigitalBridge Group, Inc. is a global digital infrastructure investment firm. The company owns, invests in and operates businesses such as cell towers, data centers, fiber, small cells, and edge infrastructure. Headquartered in Boca Raton, DigitalBridge has offices in Los Angeles, New York, Denver, London, and Singapore. As of June 2025, DigitalBridge had US$106 billion of assets under management.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

DBRG vs MYGN — Head-to-Head

Bigger by revenue
MYGN
MYGN
2.0× larger
MYGN
$209.8M
$105.7M
DBRG
Growing faster (revenue YoY)
DBRG
DBRG
+4.5% gap
DBRG
4.1%
-0.4%
MYGN
Faster 2-yr revenue CAGR
DBRG
DBRG
Annualised
DBRG
19.2%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DBRG
DBRG
MYGN
MYGN
Revenue
$105.7M
$209.8M
Net Profit
$65.1M
Gross Margin
70.0%
Operating Margin
-2.7%
Net Margin
61.5%
Revenue YoY
4.1%
-0.4%
Net Profit YoY
EPS (diluted)
$0.28
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBRG
DBRG
MYGN
MYGN
Q4 25
$105.7M
$209.8M
Q3 25
$93.3M
$205.7M
Q2 25
$85.3M
$213.1M
Q1 25
$90.1M
$195.9M
Q4 24
$101.6M
$210.6M
Q3 24
$76.6M
$213.3M
Q2 24
$390.3M
$211.5M
Q1 24
$74.4M
$202.2M
Net Profit
DBRG
DBRG
MYGN
MYGN
Q4 25
$65.1M
Q3 25
$31.4M
$-27.4M
Q2 25
$31.6M
$-330.5M
Q1 25
$13.8M
$-100.0K
Q4 24
Q3 24
$13.8M
$-22.1M
Q2 24
$91.4M
$-36.7M
Q1 24
$-29.6M
$-26.0M
Gross Margin
DBRG
DBRG
MYGN
MYGN
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Q1 24
68.1%
Operating Margin
DBRG
DBRG
MYGN
MYGN
Q4 25
-2.7%
Q3 25
-13.9%
-11.3%
Q2 25
-31.2%
-154.5%
Q1 25
-11.5%
-14.8%
Q4 24
5.7%
-18.6%
Q3 24
62.4%
-9.4%
Q2 24
33.5%
-17.3%
Q1 24
-20.7%
-13.8%
Net Margin
DBRG
DBRG
MYGN
MYGN
Q4 25
61.5%
Q3 25
33.7%
-13.3%
Q2 25
37.1%
-155.1%
Q1 25
15.3%
-0.1%
Q4 24
Q3 24
18.0%
-10.4%
Q2 24
23.4%
-17.4%
Q1 24
-39.8%
-12.9%
EPS (diluted)
DBRG
DBRG
MYGN
MYGN
Q4 25
$0.28
$-0.09
Q3 25
$0.09
$-0.29
Q2 25
$0.10
$-3.57
Q1 25
$-0.01
$0.00
Q4 24
$-0.47
Q3 24
$-0.01
$-0.24
Q2 24
$0.44
$-0.41
Q1 24
$-0.28
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBRG
DBRG
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$382.5M
$149.6M
Total DebtLower is stronger
$298.8M
$119.9M
Stockholders' EquityBook value
$2.1B
$368.0M
Total Assets
$3.4B
$706.6M
Debt / EquityLower = less leverage
0.14×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBRG
DBRG
MYGN
MYGN
Q4 25
$382.5M
$149.6M
Q3 25
$358.4M
$145.4M
Q2 25
$340.7M
$74.4M
Q1 25
$349.9M
$91.8M
Q4 24
$302.2M
$102.4M
Q3 24
$294.4M
$99.9M
Q2 24
$261.2M
$97.3M
Q1 24
$247.4M
$104.3M
Total Debt
DBRG
DBRG
MYGN
MYGN
Q4 25
$298.8M
$119.9M
Q3 25
$327.9M
$119.5M
Q2 25
$298.0M
Q1 25
$296.9M
Q4 24
$296.4M
Q3 24
$295.8M
Q2 24
$295.3M
Q1 24
$366.5M
Stockholders' Equity
DBRG
DBRG
MYGN
MYGN
Q4 25
$2.1B
$368.0M
Q3 25
$2.1B
$372.8M
Q2 25
$2.0B
$388.1M
Q1 25
$2.0B
$704.9M
Q4 24
$2.0B
$701.1M
Q3 24
$2.0B
$731.7M
Q2 24
$2.0B
$740.5M
Q1 24
$1.8B
$760.0M
Total Assets
DBRG
DBRG
MYGN
MYGN
Q4 25
$3.4B
$706.6M
Q3 25
$3.5B
$728.1M
Q2 25
$3.4B
$677.3M
Q1 25
$3.4B
$1.0B
Q4 24
$3.5B
$1.0B
Q3 24
$3.5B
$1.1B
Q2 24
$3.5B
$1.1B
Q1 24
$3.5B
$1.1B
Debt / Equity
DBRG
DBRG
MYGN
MYGN
Q4 25
0.14×
0.33×
Q3 25
0.16×
0.32×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBRG
DBRG
MYGN
MYGN
Operating Cash FlowLast quarter
$259.3M
$10.6M
Free Cash FlowOCF − Capex
$258.0M
FCF MarginFCF / Revenue
244.0%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$440.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBRG
DBRG
MYGN
MYGN
Q4 25
$259.3M
$10.6M
Q3 25
$56.5M
$21.1M
Q2 25
$77.0M
$-13.6M
Q1 25
$50.3M
$-16.3M
Q4 24
$60.1M
$6.6M
Q3 24
$35.9M
$700.0K
Q2 24
$22.5M
$2.6M
Q1 24
$-27.0M
$-18.6M
Free Cash Flow
DBRG
DBRG
MYGN
MYGN
Q4 25
$258.0M
Q3 25
$56.1M
Q2 25
$76.4M
Q1 25
$50.0M
Q4 24
$56.5M
Q3 24
Q2 24
$22.3M
Q1 24
$-30.1M
FCF Margin
DBRG
DBRG
MYGN
MYGN
Q4 25
244.0%
Q3 25
60.2%
Q2 25
89.5%
Q1 25
55.5%
Q4 24
55.7%
Q3 24
Q2 24
5.7%
Q1 24
-40.4%
Capex Intensity
DBRG
DBRG
MYGN
MYGN
Q4 25
1.3%
Q3 25
0.4%
Q2 25
0.7%
Q1 25
0.3%
Q4 24
3.5%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
4.1%
Cash Conversion
DBRG
DBRG
MYGN
MYGN
Q4 25
3.99×
Q3 25
1.80×
Q2 25
2.43×
Q1 25
3.65×
Q4 24
Q3 24
2.61×
Q2 24
0.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons